Opexa Reaches Enrollment Target in Phase IIb Trial of Personalized Immunotherapy for Secondary Progressive Multiple Sclerosis
Opexa Therapeutics, 13 May 2014
Accessed on 17 May 2014 from http://www.opexatherapeutics.com/news-and-resources/press-releases/press-releases-details/2014/Opexa-Reaches-Enrollment-Target-in-Phase-IIb-Trial-of-Personalized-Immunotherapy-for-Secondary-Progressive-Multiple-Sclerosis/default.aspx.